Serzone

Serzone is a prescription drug manufactured by Bristol-Myers-Squibb to treat depression. Unlike other antidepressant drugs, Serzone was marketed as an antidepressant that was less likely to decrease a user’s sexual drive. This marketing claim dramatically increased the product sales.

Since its approval by the U.S. Food and Drug Administration (FDA) on Dec. 22, 1994, it is estimated that Serzone was prescribed and used by approximately 8.3 million people worldwide. In fact, Bristol-Myers reported worldwide sales of Serzone reached $409 million by 2001.

In June 2000, Bristol-Myers-Squibb made a change to the Serzone label which strengthened its warning about the possibility of liver problems and failure, which could lead to the need for a transplant, or even death. In Dec. 2001, the FDA instructed Bristol-Myers to issue a "black box" warning label informing physicians and patients of Serzone’s likelihood to cause life threatening liver damage. On Jan. 9, 2002, Bristol-Myers issued a manufacturer's warning advising patients of Serzone's risk of causing life threatening liver failure.

There have been 109 serious injury cases reported as a result of Serzone use since it first appeared on the market in 1994. Of those 109 serious injuries, 23 resulted in liver failure and 16 resulted in liver transplants. The onset of serious liver damage usually occurs within four months of starting treatment, and cases of liver injury have occurred as early as a few weeks after beginning treatment, or after continuous use for up to 1-2 years. In addition to the serious injuries that have occurred as a result of Serzone usage, there have been 13 deaths attributable to Serzone.

The possible side effects of Serzone include agitation, dizziness, clumsiness or unsteadiness, difficulty concentrating, memory problems, confusion, severe nausea, abdominal pain, unusually dark urine, difficult or frequent urination, fainting, skin rash or hives, yellowing of the skin or whites of the eyes (jaundice) or prolonged weight loss or loss of appetite.

If you or someone you care about has ever taken Serzone and experienced any symptoms described above, you may be entitled to a cash award. To find out more, please contact our Serzone attorneys and we will provide you with a free evaluation of your options.

For more information on Serzone, Bankruptcy, Debt Consolidation, Social Security cases, Nursing Homes Neglect, Personal Injury cases and Medical Malpractice, please send Brock & Stout injury lawyers an E-Mail.

1-800-884-9600

Serzone lawyers and Serzone side effects attorneys serving Southeast Alabama, Southwest Georgia and the Florida Panhandle including the cities of Dothan, Enterprise, Andalusia, Ozark, Fort Rucker, Geneva, Daleville, Eufaula, Auburn, Opelika, Phenix City, Abbeville, Brewton, Troy, Headland, Opp, Greenville, Marianna, Chipley, and Bonifay.

It Won't Cost You Anything To See If We Can Help
Contact Us

ABOUT OUR FIRM | MEET OUR ATTORNEYS | PERSONAL INJURY | NURSING HOME
SOCIAL SECURITY | BANKRUPTCY | PHARMACEUTICAL LITIGATION | COMMON LEGAL QUESTIONS | CONTACT US | SITE MAP 

Alabama State Bar Rules require the following: No representation is made that the quality of legal service to be performed is greater than the quality of legal services performed by other lawyers. The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.

The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask the Lawyer to send you written information about their qualifications and experience.

Web Site DesignCopyright © 2002 by Carbon 42